WO1986004926A1 - Analyse de substrats degradables par detection electrochimique d'especes redox - Google Patents
Analyse de substrats degradables par detection electrochimique d'especes redox Download PDFInfo
- Publication number
- WO1986004926A1 WO1986004926A1 PCT/GB1986/000095 GB8600095W WO8604926A1 WO 1986004926 A1 WO1986004926 A1 WO 1986004926A1 GB 8600095 W GB8600095 W GB 8600095W WO 8604926 A1 WO8604926 A1 WO 8604926A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- redox
- enzyme
- species
- assay
- mediator
- Prior art date
Links
- 238000003556 assay Methods 0.000 title claims abstract description 66
- 239000000758 substrate Substances 0.000 title claims abstract description 45
- 238000000835 electrochemical detection Methods 0.000 title claims abstract description 12
- 102000004190 Enzymes Human genes 0.000 claims abstract description 111
- 108090000790 Enzymes Proteins 0.000 claims abstract description 111
- 229940088598 enzyme Drugs 0.000 claims abstract description 111
- 229920000642 polymer Polymers 0.000 claims abstract description 44
- 230000000694 effects Effects 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 33
- 230000029087 digestion Effects 0.000 claims abstract description 21
- 108010015776 Glucose oxidase Proteins 0.000 claims abstract description 20
- 239000004366 Glucose oxidase Substances 0.000 claims abstract description 20
- 229940116332 glucose oxidase Drugs 0.000 claims abstract description 20
- 235000019420 glucose oxidase Nutrition 0.000 claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 230000009870 specific binding Effects 0.000 claims abstract description 9
- 241000894007 species Species 0.000 claims description 79
- 102000004139 alpha-Amylases Human genes 0.000 claims description 29
- 108090000637 alpha-Amylases Proteins 0.000 claims description 29
- 229940024171 alpha-amylase Drugs 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 28
- 238000012546 transfer Methods 0.000 claims description 26
- 239000000178 monomer Substances 0.000 claims description 20
- 229920002521 macromolecule Polymers 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 230000004044 response Effects 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 11
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 8
- 238000005259 measurement Methods 0.000 claims description 8
- 238000006479 redox reaction Methods 0.000 claims description 8
- 238000009739 binding Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 6
- 150000002605 large molecules Chemical class 0.000 claims description 6
- 239000003446 ligand Substances 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 230000009919 sequestration Effects 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 4
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 3
- 238000002848 electrochemical method Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 abstract description 15
- 230000003321 amplification Effects 0.000 abstract description 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 2
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 20
- 229920000856 Amylose Polymers 0.000 description 17
- 150000004676 glycans Chemical class 0.000 description 13
- 229920001282 polysaccharide Polymers 0.000 description 13
- 239000005017 polysaccharide Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000002484 cyclic voltammetry Methods 0.000 description 12
- 230000005518 electrochemistry Effects 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 239000012491 analyte Substances 0.000 description 8
- 230000003197 catalytic effect Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000012528 membrane Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000002502 liposome Substances 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000007717 exclusion Effects 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 102000015439 Phospholipases Human genes 0.000 description 2
- 108010064785 Phospholipases Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- -1 bis-cyclopentadienyl iron Chemical compound 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012875 competitive assay Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 108091023020 Aldehyde Oxidase Proteins 0.000 description 1
- 102100036826 Aldehyde oxidase Human genes 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical class CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100025287 Cytochrome b Human genes 0.000 description 1
- 108010075028 Cytochromes b Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108010057573 Flavoproteins Proteins 0.000 description 1
- 102000003983 Flavoproteins Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 108050009363 Hyaluronidases Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 108010008292 L-Amino Acid Oxidase Proteins 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 102000007070 L-amino-acid oxidase Human genes 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 108010042687 Pyruvate Oxidase Proteins 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 108010060059 Sarcosine Oxidase Proteins 0.000 description 1
- 102000008118 Sarcosine oxidase Human genes 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 241000860832 Yoda Species 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- 108010048916 alcohol dehydrogenase (acceptor) Proteins 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000012911 assay medium Substances 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- 108010059049 capsular-polysaccharide galactohydrolase Proteins 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VTDVIWPHJXANHZ-UHFFFAOYSA-M chloro(cyclopenta-2,4-dien-1-ylidene)methanolate;cyclopenta-1,3-diene;iron(2+) Chemical compound [Fe+2].C=1C=C[CH-]C=1.[O-]C(Cl)=C1C=CC=C1 VTDVIWPHJXANHZ-UHFFFAOYSA-M 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GPRSOIDYHMXAGW-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopentanecarboxylic acid iron Chemical compound [CH-]1[CH-][CH-][C-]([CH-]1)C(=O)O.[CH-]1C=CC=C1.[Fe] GPRSOIDYHMXAGW-UHFFFAOYSA-N 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001736 differential pulse polarography Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007812 electrochemical assay Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 108010060938 metalloflavoproteins Proteins 0.000 description 1
- MFPODHWDVFPSKC-BTVCFUMJSA-N methanol;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O MFPODHWDVFPSKC-BTVCFUMJSA-N 0.000 description 1
- 108010036691 methylamine dehydrogenase Proteins 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 210000000277 pancreatic duct Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 125000001791 phenazinyl group Chemical class C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000002468 redox effect Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 150000003304 ruthenium compounds Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000001075 voltammogram Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/004—Enzyme electrodes mediator-assisted
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
Definitions
- the present invention concerns the electrochemical detection of redox species in a medium and the use of such detection to determine the occurence of a condition under which such species are liberated, produced, sequestered or discharged into a medium.
- the present invention is concerned with the electrochemistry of mediators in combination with degradable substrates, such as polymers, and with an electrochemical assay which is in one aspect particularly concerned with an assay for the presence of, or amount of, polysaccharide complexes in a sample, but which extends a general assay for detecting the presence of, monitoring the level of or determining the concentration of compounds containing polymeric structures as set forth below and including but not limited to; celluloses, pectins, galactosides, hyaluronic acids, lipids, peptides, nucleic acids and specific binding partners in immunoassay.
- an assay system for enzymes having a polymerase or depolymerase activity and for other chemical or physical conditions resulting in the making or breaking of chemical bonds, or changes in physical state or condition.
- ⁇ -Amylase (1, 4- ⁇ -D-glucan glucanohydrolase, E.C.3.2.1.1.
- an enzyme which catalyses the hydrolysis of 1,4- ⁇ -glycosidic linkages of polysaccharides (e.g. starches and glycogen) and of oligosaccharides to yield maltose and other simple cleavage products.
- ⁇ -amylase in serum or urine is due to at least two distinct isoenzymes; a first ⁇ -amylase from the pancreas and a second from the saliva. This endoenzyme is extensively measured in clinical laboratories for the diagnosis of acute pancreatitis and obstruction of the pancreatic duct. The determination of ⁇ -amylase activity is also important for the food industry, especially for starch converting plants, breweries and other fermentation facilities.
- amyloclastic i.e. starch-iodine
- saccharogenic i.e. saccharogenic
- chromogenic i.e. chromogenic
- Hydrogen peroxide produced by the oxidation of glucose by glucose oxidase is determined by a polarographic electrode of the type used in the Yellow Springs Glucose Analyser.
- Electroanal. Chera. 194 123-130 (1985)] is based upon the electrochemical detection of hydrolysis products from modified blue starch, the subs-trate normally used for chromogenic determination of ⁇ -amylase activity.
- Simionescu discusses the attachment of ferrocene carboxylic acid to cellulose and to Polyvinylacetate by ester linkages, and the attachment of ferrocene carboxaldehyde to polyvinyl pyrrolidinone via an aldol condensation.
- I t is suggested by Simionescu that the adduct acts as an effective slow-release agent for the treatment of anaemia.
- Enzyme/substrate pairs whose electrochemical behaviour in association with mediator compounds have been studied by the Applicants include those listed in Table 1.
- Oxidase Pyruvates L-Amino Acid Oxidase L-Amino Acids Aldehyde Oxidase Aldehydes Xanthine Oxidase Xanthines Glucose Oxidase Glucose Sarcosine Oxidase Sarcosine
- Ferrocenes have: (a) a wide range of redox potentials accessible through substitution of the cyclopentadienyl rings which can be functionalised;
- Eo is in mV vs a standard calomel electrode, ⁇ is measured in cm -1 M -1 1 -1 .
- mediator compounds include those listed in Table 3. It should be noted that not all mediator compounds will mediate effectively between a particular redox enzyme and an electrode surface. The selection of the optimum mediator is to some extent determined by the particular enzyme in use, under a given set of chemical and/or physical conditions. TABLE 3 Mediator Compounds
- Viologens and their polymers
- the present invention concerns the use of an electro-chemical detection of redox species in a medium to determine the occurence of a condition under which such species are liberated, produced, released or sequestered, wherein such production or release is enabled by the digestion, build-up or disruption of a macroraolecular species
- digestion includes the breakage of chemical bonds under a range of conditions, including enzymic digestion of the macromolecular species, build-up includes the polymerisation of a number of monomers, sub-units or oligomers into a macromolecule, and, disruption includes the breakage of bonds by physical processes such as the disruption of lysosomes (including liposomes) or micelles.
- an assay system comprising; a) a macroraolecular species comprising at least in part a component, activatable on digestion or disruption of the macroraolecular species to produce, liberate, sequester or release directly, or facilitate indirect production, liberation, sequestration or release of redox species within a medium and, b) electrode means responsive to the presence of the redox species, for electrochemical detection or measurement of the redox species in the medium, whereby the said detection or measurement is related to the digestion or disruption of the macroraolecular species, as enabled, on occurence of a predetermined condition, thereby being capable of a response to the presence type or amount of the macromolecular species, and/or of the said presence or amount of digestion or disruption and/or of circumstances affecting the indirect production of the redox species.
- This aspect of the invention provides for the direct or indirect production or release of a redox species following the digestion or disruption of the macroraolecular species, and may be employed to determine when conditions occur under which such a macromolecular species is digested or disrupted. For example, it is possible to determine the occurence of a condition which causes a macromolecular species composed of a plurality of linked subunits, to separate into individual sub-units, by labelling some or all of the individual components with a redox species. The redox behaviour of the separate labelled sub-units differs from that of the complexed sub-units and separation may be detected thereby.
- this aspect of the present invention is seen to comprise a system capable of detecting a redox species in combination with a redox species bound to or held inactive as a component of a macromolecule. On the occurrence of a pre-determined condition vnicn releases the redox compound from its inactive condition or location, a detectable signal is produced.
- the redox species may be chemically linked to a solid substrate, or linked to a colloidally or otherwise dispersed, or disolved molecular species inhibiting the redox activity of the species. Such linkage prevents free movement of the redox species and so alters the electrochemical response of the species.
- the redox species may be chemically linked to a suitably large molecule, to prevent the passage of the redox species across a molecular exclusion membrane or other "molecular filter".
- Suitable solid substrates include the wall of an assay vessel, or a suitable insert, such as a region of an electrode other than the working electrode surface or a mass of beads.
- this aspect of the invention comprises an assay system including; a redox enzyme, a mediator compound capable of facilitating the transfer of charge from the redox enzyme to the electrode, and, a substrate for the redox enzyme; wherein; a) the component comprises one of said redox enzyme or said mediator, and, b) the macromolecular species comprises a large-molecule immobiliser material linked to the component, whereby upon digestion or disruption of the macromolecular species, the redox enzyme, substrate and mediator interact to provide the redox species; at the electrode.
- the macromolecular species includes a redox active component which will facilitate the transfer of charge from the enzyme to an electrode, when the component is released from the macromolecule. Consequently, the present invention provides method of assay including the steps of; a) preparing a mixture containing known amounts of; i) a redox enzyme, ii) a mediator compound capable of transferring charge from the redox enzyme to an electrode on occurence of a redox reaction, and, iii) a substrate for the redox reaction, wherein at least one of components i) or ii) is linked to a macromolecule, whereby charge transfer to the electrode surface is restricted, b) treating the mixture with an agent suspected of being capable of effectively liberating the component linked to the macromolecule, and, c) measuring the charge transfer to the electrode surface, whereby the presence of the agent may be determined.
- one of the components i) or ii) is absent from the medium. being linked to the macromolecule.
- the enzyme/ mediator/ substrate system is completed, allowing charge transfer to the electrode to produce a detectable signal.
- the macroraolecular species is a polymer, in which some or all of the monomeric sub-units are labelled with a component of the enzyme/ mediator/ substrate system, and the agent capable of liberating the component can be a depolymerase enzyme suspected of being in the sample.
- an assay system comprising; a) a reagent system capable of facillitating the production or release of redox species within a medium in the presence of a component produced or released from a macromolecular species by digestion or disruption of the macroraolecular species, and, b) at least one electrode responsive to the presence of the redox species, for electrochemical detection of the redox species in the medium.
- the analyte of the assay system may be the macromolecular species itself, and the assay system is such that in the presence of the macroraolecular species, the reagent system produces redox species which can be detected at the electode.
- the present invention extends to an assay system including either; a redox enzyme or a mediator corapound capable of facilitating the transfer of charge from the redox enzyme to the electrode, and a substrate for the redox enzyme; wnerein; a) the component comprises one of said redox enzyme or mediator, b) the system further comprises a further enzyme to produce or release the component in the presence of the macromolecular species, wherein on treatment of the assay system with a sample containing the macromolecular species charge is consequently transferred via the mediator compound to the said electrode.
- the component of the redox enzyme/ substrate/ mediator system is released when the macroraolecular species is acted upon by the further enzyme.
- the macromolecular species may be a modified polymer, such as a polysaccharide
- the further enzyme may be a polysaccharide depolymerase, such as amyloglucosidase or ⁇ -amylase.
- the present assay systems may be employed in methods of assay for specific binding reactions, such as in methods of immunoassay.
- the invention provides a method of assay including the steps of; a) preparing a mixture containing known amounts of; i) a redox enzyme, ii) a mediator compound capable of transferring charge between the redox enzyme and an electrode surface on occurence of a redox reaction, iii) a substrate for the redox reaction, and, iv) a ligand labelled with an enzyme having a depolymerase activity on a polymer, wherein, at least one of components i) or ii) is linked to the polymer whereby charge transfer is restricted until the component is liberated into the mixture, b) treating the mixture with a sample suspected of containing an antiligand capable of a specific binding reaction with the ligand, and, c) measuring the pertubation of charge transfer, whereby the presence of the reactive species may be determined.
- a method suitable for the detection of a specific binding reaction in which the ligand is labelled with an enzyme having a depolymerase activity.
- This activity is detected by the liberation from a macroraolecular substrate by the enzyme of a component of the redox enzyme/ mediator/ substrate system.
- charge transfer occurs at the electrode.
- the extent to which this charge transfer occurs is determined by the activity of the depolymerase, especially in the instance where the product of the depolymerase is a mediator to the redox enzyme.
- the depolymerase activity is affected with a consequent effect on the transfer of charge to the electrode.
- the specific binding reaction may be detected indirectly.
- the macromolecule can be a polymer molecule, by which term we intend to include homopolymers, copolymers or large-molecular chains with related but different units e.g. protein, other polypeptide-linked substances and nucleic acids.
- the immobiliser can comprise a liposome, attackable by a ohospnolipase.
- the present invention extends to an assay system for an enzyme having a polymerase activity comprising; a) a quantity of monomer or oligomer capable of being condensed into a polymer, b) an enzyme having a redox activity on the said monomer or oligomer, c) a mediator corapound capable of transferring charge from the enzyme (b) to an electrode when the enzyme (b) is ⁇ atalytically active, wherein on treatment of the assay system with a sample containing a polymerase capable of polymerising the said oligomers or monomer, the rate of redox activity of the enzyme (b), and consequently the amount of charge transferred via the mediator compound to the said electrode, is reduced by the polymerisation of the monomer or oligomer.
- the term "depolymerase” is intended to mean any enzyme which is capable of degrading a polymer into monomers or oligomers or a mixture of products. This includes, out is not limited to hydrolase enzymes, peptidases, hyaluronidases, galactosidases, and nucleases. "Polymerase” has the reverse meaning, and includes both those polymerase enzymes which use a template (such as the enzymes involved in RNA and DNA synthesis) and those enzymes which while manufacturing polymers do not require a template.
- the mediator compound is chemically attached to the polymer, so that its "mediator” or charge transfer ability is reduced or eliminated until the polymer is attacked, it has been found preferable that the mediator is a metallocene. and more preferably ferrocene or a derivative thereof. It should however be noted that other, non-metal, mediators as listed above in Table 3 can also oe used, provided that the mediator activity is recovered when the mediator is released from the immobilising large molecule.
- Ferrocene and derivatives thereof are particularly suitable as mediators in the present invention, as they have been shown to retain their activity even when considerable modification and/ or substitution of the ferrocene molecule has been performed.
- the depolymerase activity may be that of a hydrolase and particular utility has been found with those embodiments in which the depolymerase is specific to a polysaccharide.
- the second enzyme is preferably selected such that it has a a redox activity on the oligo- and mono-saccharide fragments produced by the action of the depolymerase.
- the redox enzyme is glucose oxidase or glucose dehydrogenase.
- amyloglucosidase (E.C.3.2.1.3), hydrolyses ⁇ -1,4 and ⁇ -1,6-glucan linkages in polysaccharides to produce monomers quantitatively.
- the polymer substrate is a polysaccharide, amyiose, which has been modified by covalent attachment of ferrocene via an ester linkage. After digestion of the polymer by the hydrolytic enzyme, the products can mediate between glucose oxidase and an electrode, in the presence of a glucose substrate, and generate a measurable electrical signal.
- ⁇ -amylase acts on a second ferrocene-labelled insoluble substrate to produce soluble oligomers which can be detected amperometrically.
- the cleavage products are capable of acting as electron acceptors for glucose oxidase in the enzyme catalysed oxidation of glucose, thus giving rise to an amplification of the observed curren.t.
- polymer-bound ferrocene is electrocheraically silent, that is. it cannot act as an electron acceptor for glucose oxidase and does not exhibit reversible or quasi-reversible electrochemistry.
- Figure 1 shows a schematic drawing of an assay system in which the analyte is a polymer, and in which the substrate of the enzyme from which charge transfer occurs is a monomer or an oligomer of the polymer,
- Figure 2 shows an assay system in which the analyte is a depolymerase, and in which a mediator compound is immobilised as a constituent of a polymer until monomers and oligomers having mediator activity are released by the action of the depolymerase,
- Figure 3 shows an assay system in which the analyte is a reagent capable of releasing immobilised enzyme into the free portion of the assay system, and in which both substrate and a mediator for that enzyme are present in the free portion
- Figure 4 shows in schematic form a system in which the release of the mediator compound into the assay medium is accompanied by the cleavage of a specific type of chemical bond
- Figure 5 shows an extension of the technique illustrated in figure 5, in which a molecular exclusion membrane is employed
- Figure 6 shows in schematic form the operation of a assay system in which the electrochemical response of the mediator compound is determined directly.
- Figure 7 shows a) DC cyclic voltammogram of 3mg of a ferrocene derivative of a polysaccharide in 1ml K 2 HPO 4 :NaCl buffer, pH 7.0 @ 37°C, b) DC cyclic voltammogram of the solution (a) after incubation at 37°C for 10min. with
- Figure 8 shows a) DC cyclic voltammogram of 3mg of a ferrocene derivative of a polysaccharide in 1ml
- Figure 9 Shows a calibration plot of ⁇ -amylase concentration, against measured current.
- Figure 10 Shows a calibration plot of IgG- ⁇ -amylase concentration, against measured current.
- FIG 1 there is shown a schematic diagram of an assay system in which a polymeric species (A n ) is the analyte. and the substrate for an enzyme/ mediator system comprises a monomer or oligomer of the polymer (A n ).
- the polymeric species (A n ) is degraded by a site or component specific depolymerase enzyme (Q) to produce shortened polymers (A m ) and monomers (S) possibly also together with diraers, trimers, etc. as discussed above.
- Q site or component specific depolymerase enzyme
- the structure of the polymer (A n ) is known and the action of the enzyme (Q) is accurately predicted, it is possible to design a system in which either or both of the oligomers (A m ) and the monomer (S) are a substrate for the redox enzyme (E), which is usually an oxidase, and to which redox enzyme a mediator such as ferrocene is available.
- E redox enzyme
- any free monomer (S) is pre-existing in the assay mixture, it is possible to perform a corrective assay for the polymer using the differential between the current in the presence and the absence of the depolymerase ( Q). It is envisaged that such measurements could be made simultaneously in a system which has more than one sensing electrode and a plurality of compartments separated by suitable molecular-exclusion membranes.
- the illustrated system can also be used to assay for the depolymerase (Q), by providing an excess of polymer (A n ) in the assay mixture and omitting the depolymerase (Q).
- the polymer is not a substrate of the enzyme (E) no current will be detected at the electrode until digestion of the polymer (A n ) occurs, thus the presence of the depolymerase (Q) can be detected.
- an assay system contains substrate (S), enzyme (E), and mediator, but the depolymerase (Q) is replaced by a polymerase, which has the same substrate (S) as the enzyme (E) and which produces a polymer which is not a substrate for the enzyme (E), then a competitive reaction will occur between the consumption of substrata (S) at tne enzyme (E) and the polymerisation of (S) into an inactive species.
- the current generated by such a systera would be changed if any of the rate or concentration parameters, such as activity of polymerase or enzyme (E), or such as availiabillity of substrate (S) were altered.
- Figure 2 Assay for Depolymerase.
- Figure 2 shows an assay systera in which the analyte is a depolymerase (R), and in which a mediator compound is immobilised as a constituent of a polymer (B n ) until monomers and oligomers having mediator activity are released by the action of the depolymerase (R).
- mediator is liberated and is free to tranfer charge from the enzyme E to the electrode (1).
- the substrate (S) and the product (P) of the enzyme (E) are not determined by the nature of the depolymerase. and consequently a wide range of enzymes, substrates and mediators can be employed with this particular embodiment of the invention.
- a variant of this technique is directed at the assay of a further analyte and causes a change in the behavior of the assay system shown in the figure by its effect upon at least one of the rate or concentration parameters, such as activity of depolymerase (R).
- the depolymerase (R) is covalently attached to one or other of a pair of specific binding partners such as antigen/antibody.
- the depolymerase (R) with antibody attached retains its activity and the systera function in an identical fashion to that described above.
- This technique could be used to assay antibody concentration or, in sandwich assays or hetergeneous competitive assays, to assay or monitor antigen concentration. This configuration is particularly suitable for the estimation of high molecular-weight antigens.
- the liberation of the immobillised component accompanies the disruption of a large transfer restraining molecule or aggregation of molecules.
- the immobiliser can comprise a liposome containing and confining therewithin a mediator compound and attackable by a phospholipase to release the mediator into the assay system and to thus allow electron transfer to occur.
- the analyte is a reagent capable of releasing immobilised enzyme (E) into the free portion of the assay system, and in which both substrate (S) and a mediator for enzyme (E) are present in that free portion.
- the enzyme (E) may be immobilised in several ways.
- the enzyme (E) can be contained within a liposome (L) and released by the action of a by a phospholipase (T) on the liposome.
- Figures 4a and 4b show a systera which comprises an assay for a peptide bond hydrolysing condition.
- the enzyme (E) may perform its catalytic activity upon the substrate (S), in this instance present in solution.
- a mediator (F) is attached via a linker group L 1 , to a structure L 2 including a peptide bond P.
- the mediator/L 1 conjugate may freely diffuse and transfer charge from the enzyme to the electrode, thereby giving a detectable signal, and indicating that the peptide bond P has been broken.
- Figure 5 shows an alternative system to that shown in Figure 4 which makes use of a molecular exclusion membrane (3) to separate the mediator (M) which is bound to a large molecule (X), and the enzyme (E), both of which are too large to pass through the membrane (3).
- breakage of the linkage between the mediator (M) and the large molecule allows the mediator to diffuse through the membrane and mediate the transfer of charge from the enzyme E to the electrode.
- FIG 6 a system is shown which lacks the redox enzyme generally referred to as E in the other figures.
- the only enzyme which is required in the assay systera is that which depolymerises a polymer (C n ) which has mediator attached thereto.
- mediator is liberated by a depolymerase (R). It is possible to obtain a response to the presence of the electrochemically active monomer at the electrode (1), from which the activity of the depolymerase can be determined. It should again be noted that presence of depolymerase (R) in the assay system for even a short time will cause a permanent change in the electrode response.
- EXAMPLE 1 Preparation of 6-O-ferrocene-amylose
- 6-O-ferrocene-amylose was prepared as described in Methods in Carbohydrate Chemistry Vol IV p 300 for the preparation of 6-O-tosyl-amylose.
- the centrifuged product was washed with twice with each of methanol, water and acetone and finally again with methanol to leave a clean solid and colourless supernatant.
- EXAMPLE 2 Electrochemistry of ferrocene-araylose in a three electrode cell with a graphite working electrode
- the cell contained a 1 cm 2 platinum gauze counter electrode and a saturated calomel reference electrode. All potentials were referred to the saturated calomel electrode (SCE).
- SCE saturated calomel electrode
- the buffer used for .electrochemical experiments was 0.1M phosphate buffer (pH 7.0) containing 50mM glucose.
- the ferrocene-amylose conjugate (3.0 mg) was suspended in phosphate buffer (10 mis) and sonicated for 2 mins to produce a finely dispersed suspension. After sonication, the suspension was placed in the sample compartment of the electrochemical cell and mixed thoroughly using a magnetic stirrer.
- the d.c. cyclic voltammogram of the suspension was recorded over the potential range 0 to +650 mV vs SCE.
- the cyclic voltammogram of the ferrocene-amylose complex suspended in buffer showed no direct electrochemistry at the working electrode.
- Amyloglucosidase (1 mg) was added to the electrochemical cell and the sample was thoroughly mixed. The cyclic voltammogram of the solution was recorded at 5 and 15 mins after the addition of amyoglucosidase. On addition of amyloglucosidase, electrochemistry due to the release of 6-O-ferrocsnoyl glucose from the complex under the action of the enyzme, was observed.
- EXAMPLE 4 Electrochemistry of ferrocene-amylose in the presence of amyloglucosidase, glucose oxidase and glucose.
- glucose 50 ⁇ l of a 1M solution in acetate buffer, pH 4.8
- glucose oxidase 50 ⁇ l of a 3 rag ml -1 solution in acetate buffer, pH 4.8
- the following examples (5-10) relate to the action of ⁇ -amylase in hydrolysing amylose polymer and derivates thereof.
- ⁇ -araylase was conjugated to bovine IgG using glutaraldehyde.
- ⁇ -amylase (24rag) and IgG (10rag) were dissolved in 2ml phosphate buffer pH 6.8 (0.1M) to this 60 ⁇ l of a 10% aqueous solution of glutaraldehyde was added with gentle stirring. The solution was left to stand for 30min. The reaction was terminated by the addition of 100 ⁇ l of a 1% ethanolamine solution.
- the conjugate was purified using FPLC ["Fast Protein Liquid Chromatography"; trade-name, of Pharmacia] using a gelfiltration column.
- the IgG content of the conjugate was assessed using goat-antibovine IgG labelled with alkaline phosphatase.
- EXAMPLE 6 Three-electrode system, electrochemistry of 6-O-ferrocene-amylose in the presence of hog-pancreas ⁇ -amylase.
- EXAMPLE 7 Three-electrode system, electrochemistry of 6-O-ferrocene-amylose in the presence of hog pancreas ⁇ -araylase, GOD and glucose
- FIG. 8c shows a cyclic voltammogram as for example 6, but with the addition of 40 ⁇ l of a 1M solution of glucose and 10 ⁇ l of a 2.3mM solution of glucose oxidase.
- the catalytic current from the breakdown products was estimated as 3 ⁇ A at 500mV. It should be noted that in the absence of of ⁇ -amylase, the species with a redox peak at 550mV did not show catalytic behaviour when glucose oxidase was added to the solution.
- EXAMPLE 8 Three-electrode system, electrochemistry of 6-O-ferrocenoyl-amylose in the presence of salivary ⁇ -araylase, GOD and glucose
- FIG. 8a shows a DC cyclic voltammogram of 3mg of a ferrocene derivative of a polysaccharide in lml K 2 HPO 4 :NaCl buffer @ 37°C with 50 ⁇ l of human saliva.
- Figure 8b shows a cyclic voltammogram as shown in figure 8a, but with the addition of 40 ⁇ l of a 1M solution of glucose and 10 ⁇ l of a 2.3mM solution of glucose oxidase.
- Normal human serum has an ⁇ -araylase activity of about 1500 U/l. Therefore the effect of 1 U/ral ⁇ -amylase (final concentration) on 3mg amylose-ferrocene polymer was investigated under the conditions described above. The catalytic current measured under these conditions was approximately 90nA,
- Ferrocene-amylose polymer (3 mgs/ml) was sonicated in phosphate buffer pH 7.0 (0.1M) containing 50mM glucose. One ml of this suspension was added to an electrochemical cell, and varying amounts of ⁇ -amylase were added. After a 10 minute incubation, excess glucose oxidase was added and the catalytic current measured at +550mV vs SCE a dose/response curve was obtained. The response curve is shown in figure 9.
- Example 10 Dose/response curve to antibodies labelled with ⁇ -amylase.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Utilisation d'une technique de détection électrochimique d'espèces rédox (MR) dans un milieu pour déterminer l'existence d'une condition dans laquelle ces espèces sont produites ou libérées, cette production ou libération étant provoquée par la digestion ou la dissociation d'une espèce macromoléculaire (An). L'invention décrit un procédé d'analyse d'un polymère, d'une enzyme de dépolymérase et d'un agent liant sécifique marqué, où un polymère (An) est marqué avec un composant d'un système médiateur/enzyme/substrat qui reste inactif jusqu'au moment où il est libéré en solution. Des électrodes dans le milieu déterminent l'existence d'une condition dans laquelle des espèces rédox sont produites par le système médiateur/enzyme/substrat ou libérés en solution. Lorsqu'on utilise l'activité de médiateur, par ex., du ferrocène en glucose oxydase, on prévoit une étape d'amplification.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8504522 | 1985-02-21 | ||
GB858504522A GB8504522D0 (en) | 1985-02-21 | 1985-02-21 | Electrochemistry of mediators |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1986004926A1 true WO1986004926A1 (fr) | 1986-08-28 |
Family
ID=10574875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1986/000095 WO1986004926A1 (fr) | 1985-02-21 | 1986-02-21 | Analyse de substrats degradables par detection electrochimique d'especes redox |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0229765A1 (fr) |
JP (1) | JPS62501932A (fr) |
AU (1) | AU5516686A (fr) |
CA (1) | CA1239191A (fr) |
GB (2) | GB8504522D0 (fr) |
WO (1) | WO1986004926A1 (fr) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987002464A1 (fr) * | 1985-10-14 | 1987-04-23 | Genetics International (Uk) Inc. | Analyse avec marquage par enzyme |
WO1989001047A1 (fr) * | 1987-08-03 | 1989-02-09 | Imperial College Of Science, Technology & Medicine | Dosage enzymatique |
EP0223541A3 (fr) * | 1985-11-11 | 1989-08-23 | MediSense, Inc. | Procédés électrochimiques d'essai enzymatique |
WO1994028414A1 (fr) * | 1993-05-29 | 1994-12-08 | Cambridge Life Sciences Plc | Capteurs bases sur la transformation de polymeres |
US5427912A (en) * | 1993-08-27 | 1995-06-27 | Boehringer Mannheim Corporation | Electrochemical enzymatic complementation immunoassay |
DE19622458A1 (de) * | 1996-05-24 | 1997-11-27 | Senslab Ges Zur Entwicklung Un | Enzymatisch-elektrochemischer Einschritt-Affinitätssensor zur quantitativen Bestimmung von Analyten in wäßrigen Medien und Affinitätsassay |
US5919642A (en) * | 1994-12-19 | 1999-07-06 | Boehringer Mannheim Corporation | Competitive binding assays having improved linearity |
USRE36268E (en) * | 1988-03-15 | 1999-08-17 | Boehringer Mannheim Corporation | Method and apparatus for amperometric diagnostic analysis |
US6262264B1 (en) | 1998-06-01 | 2001-07-17 | Roche Diagnostics Corporation | Redox reversible imidazole osmium complex conjugates |
EP0442969B1 (fr) * | 1988-11-14 | 2002-02-27 | I-Stat Corporation | Biocapteurs entierement microfabriques et procede de production et utilisation de ces capteurs |
US6576102B1 (en) | 2001-03-23 | 2003-06-10 | Virotek, L.L.C. | Electrochemical sensor and method thereof |
WO2003021010A3 (fr) * | 2001-08-31 | 2003-12-04 | Univ California | Procede pour la detection specifique de marqueurs a activite d'oxydoreduction et utilisation de ceux-ci pour l'electrophorese capillaire en gel et le sequencage d'adn |
US6849216B2 (en) | 2001-03-23 | 2005-02-01 | Virotek, L.L.C. | Method of making sensor |
US7390391B2 (en) | 2001-09-14 | 2008-06-24 | Arkray, Inc. | Concentration measuring method, concentration test instrument, and concentration measuring apparatus |
WO2011158736A1 (fr) * | 2010-06-15 | 2011-12-22 | 株式会社マイクロブラッドサイエンス | Procédé de détection/quantification de molécules très rapide et d'une grande sensibilité par mesure de charges faisant appel à une enzyme capable de générer de l'électricité et pièce et dispositif de détection associés |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE20017268U1 (de) * | 2000-10-07 | 2001-03-29 | DECHEMA Gesellschaft für Chemische Technik und Biotechnologie eV, 60486 Frankfurt | Elektrochemische Messzelle zur Bestimmung der Zellzahl und Aktivität von biologischen Systemen |
GB0205455D0 (en) * | 2002-03-07 | 2002-04-24 | Molecular Sensing Plc | Nucleic acid probes, their synthesis and use |
GB2419880B (en) * | 2004-10-22 | 2008-04-30 | E2V Tech | Monitoring enzyme-substrate reactions |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233403A (en) * | 1978-02-27 | 1980-11-11 | E. I. Du Pont De Nemours And Company | Amylase assay |
EP0034122B1 (fr) * | 1980-02-12 | 1983-09-21 | Pentapharm A.G. | Dérivés de tripeptides et leur utilisation dans la détermination d'enzymes |
EP0089626A2 (fr) * | 1982-03-19 | 1983-09-28 | G.D. Searle & Co. | Procédé pour la préparation de polypeptides à l'aide d'un polymère d'acides aminés chargés et une exopeptidase |
EP0125136A2 (fr) * | 1983-05-05 | 1984-11-14 | MediSense, Inc. | Systèmes d'essai utilisant plus d'une enzyme |
EP0142301A2 (fr) * | 1983-10-25 | 1985-05-22 | Serono Diagnostics Limited | Procédés d'essai |
EP0149339A2 (fr) * | 1983-12-16 | 1985-07-24 | MediSense, Inc. | Essai pour acides nucléiques |
EP0150602A2 (fr) * | 1983-12-20 | 1985-08-07 | Genetics International, Inc. | Composés de bore et carbone dans des électrodes de transfert d'électrons |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1226036A (fr) * | 1983-05-05 | 1987-08-25 | Irving J. Higgins | Materiel d'analyse et ses electrodes-sondes |
CA1219040A (fr) * | 1983-05-05 | 1987-03-10 | Elliot V. Plotkin | Mesure de reactions catalysees par des enzymes |
-
1985
- 1985-02-21 GB GB858504522A patent/GB8504522D0/en active Pending
-
1986
- 1986-02-21 EP EP19860901446 patent/EP0229765A1/fr not_active Withdrawn
- 1986-02-21 JP JP61501282A patent/JPS62501932A/ja active Pending
- 1986-02-21 GB GB08604368A patent/GB2173313A/en not_active Withdrawn
- 1986-02-21 AU AU55166/86A patent/AU5516686A/en not_active Abandoned
- 1986-02-21 CA CA000502464A patent/CA1239191A/fr not_active Expired
- 1986-02-21 WO PCT/GB1986/000095 patent/WO1986004926A1/fr not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233403A (en) * | 1978-02-27 | 1980-11-11 | E. I. Du Pont De Nemours And Company | Amylase assay |
EP0034122B1 (fr) * | 1980-02-12 | 1983-09-21 | Pentapharm A.G. | Dérivés de tripeptides et leur utilisation dans la détermination d'enzymes |
EP0089626A2 (fr) * | 1982-03-19 | 1983-09-28 | G.D. Searle & Co. | Procédé pour la préparation de polypeptides à l'aide d'un polymère d'acides aminés chargés et une exopeptidase |
EP0125136A2 (fr) * | 1983-05-05 | 1984-11-14 | MediSense, Inc. | Systèmes d'essai utilisant plus d'une enzyme |
EP0142301A2 (fr) * | 1983-10-25 | 1985-05-22 | Serono Diagnostics Limited | Procédés d'essai |
EP0149339A2 (fr) * | 1983-12-16 | 1985-07-24 | MediSense, Inc. | Essai pour acides nucléiques |
EP0150602A2 (fr) * | 1983-12-20 | 1985-08-07 | Genetics International, Inc. | Composés de bore et carbone dans des électrodes de transfert d'électrons |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987002464A1 (fr) * | 1985-10-14 | 1987-04-23 | Genetics International (Uk) Inc. | Analyse avec marquage par enzyme |
EP0223541A3 (fr) * | 1985-11-11 | 1989-08-23 | MediSense, Inc. | Procédés électrochimiques d'essai enzymatique |
WO1989001047A1 (fr) * | 1987-08-03 | 1989-02-09 | Imperial College Of Science, Technology & Medicine | Dosage enzymatique |
USRE36268E (en) * | 1988-03-15 | 1999-08-17 | Boehringer Mannheim Corporation | Method and apparatus for amperometric diagnostic analysis |
EP0442969B1 (fr) * | 1988-11-14 | 2002-02-27 | I-Stat Corporation | Biocapteurs entierement microfabriques et procede de production et utilisation de ces capteurs |
WO1994028414A1 (fr) * | 1993-05-29 | 1994-12-08 | Cambridge Life Sciences Plc | Capteurs bases sur la transformation de polymeres |
US5427912A (en) * | 1993-08-27 | 1995-06-27 | Boehringer Mannheim Corporation | Electrochemical enzymatic complementation immunoassay |
US6110696A (en) * | 1993-08-27 | 2000-08-29 | Roche Diagnostics Corporation | Electrochemical enzyme assay |
US5919642A (en) * | 1994-12-19 | 1999-07-06 | Boehringer Mannheim Corporation | Competitive binding assays having improved linearity |
DE19622458A1 (de) * | 1996-05-24 | 1997-11-27 | Senslab Ges Zur Entwicklung Un | Enzymatisch-elektrochemischer Einschritt-Affinitätssensor zur quantitativen Bestimmung von Analyten in wäßrigen Medien und Affinitätsassay |
DE19622458C2 (de) * | 1996-05-24 | 1998-03-26 | Senslab Ges Zur Entwicklung Un | Enzymatisch-elektrochemischer Einschritt-Affinitätssensor zur quantitativen Bestimmung von Analyten in wäßrigen Medien und Affinitätsassay |
US6221238B1 (en) | 1996-05-24 | 2001-04-24 | Ufz-Umweltforschungszentrum Leipzig-Halle Gmbh | Enzymatic-electrochemical one-shot affinity sensor for the quantitative determination of analytes for aqueous media and affinity assay |
US6294062B1 (en) | 1998-06-01 | 2001-09-25 | Roche Diagnostics Corporation | Method and device for electrochemical immunoassay of multiple analytes |
US6262264B1 (en) | 1998-06-01 | 2001-07-17 | Roche Diagnostics Corporation | Redox reversible imidazole osmium complex conjugates |
US6352824B1 (en) | 1998-06-01 | 2002-03-05 | Roche Diagnostics Corporation | Redox reversible bipyridyl-osmium complex conjugates |
US7045310B2 (en) | 1998-06-01 | 2006-05-16 | Roche Diagnostics Operations, Inc. | Redox reversible bipyridyl-osmium complex conjugates |
USRE40198E1 (en) | 1998-06-01 | 2008-04-01 | Roche Diagnostics Operations, Inc. | Method and device for electrochemical immunoassay of multiple analytes |
US6576102B1 (en) | 2001-03-23 | 2003-06-10 | Virotek, L.L.C. | Electrochemical sensor and method thereof |
US6849216B2 (en) | 2001-03-23 | 2005-02-01 | Virotek, L.L.C. | Method of making sensor |
WO2003021010A3 (fr) * | 2001-08-31 | 2003-12-04 | Univ California | Procede pour la detection specifique de marqueurs a activite d'oxydoreduction et utilisation de ceux-ci pour l'electrophorese capillaire en gel et le sequencage d'adn |
US7390391B2 (en) | 2001-09-14 | 2008-06-24 | Arkray, Inc. | Concentration measuring method, concentration test instrument, and concentration measuring apparatus |
USRE44522E1 (en) | 2001-09-14 | 2013-10-08 | Arkray, Inc. | Concentration measuring method, concentration test instrument, and concentration measuring apparatus |
USRE45764E1 (en) | 2001-09-14 | 2015-10-20 | Arkray, Inc. | Concentration measuring method, concentration test instrument, and concentration measuring apparatus |
WO2011158736A1 (fr) * | 2010-06-15 | 2011-12-22 | 株式会社マイクロブラッドサイエンス | Procédé de détection/quantification de molécules très rapide et d'une grande sensibilité par mesure de charges faisant appel à une enzyme capable de générer de l'électricité et pièce et dispositif de détection associés |
Also Published As
Publication number | Publication date |
---|---|
GB2173313A (en) | 1986-10-08 |
AU5516686A (en) | 1986-09-10 |
EP0229765A1 (fr) | 1987-07-29 |
GB8604368D0 (en) | 1986-03-26 |
GB8504522D0 (en) | 1985-03-27 |
JPS62501932A (ja) | 1987-07-30 |
CA1239191A (fr) | 1988-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1986004926A1 (fr) | Analyse de substrats degradables par detection electrochimique d'especes redox | |
Frew et al. | Electron-transfer biosensors | |
Gregg et al. | Cross-linked redox gels containing glucose oxidase for amperometric biosensor applications | |
CA1254945A (fr) | Application des tetrathiafulvalenes dans des procedes bio-electro-chimiques | |
CA1254616A (fr) | Dosage enzymatique electrochimique | |
Tkac et al. | Improved selectivity of microbial biosensor using membrane coating. Application to the analysis of ethanol during fermentation | |
US5312527A (en) | Voltammetric sequence-selective sensor for target polynucleotide sequences | |
EP0149339B1 (fr) | Essai pour acides nucléiques | |
US5411866A (en) | Method and system for determining bioactive substances | |
EP0125867A2 (fr) | Systèmes d'essai utilisant enzymes qui ont NAD(P) comme cofacteur | |
Haghighi et al. | Prussian blue modified glassy carbon electrodes—study on operational stability and its application as a sucrose biosensor | |
Heller | Amperometric biosensors | |
Pei et al. | Xanthine and hypoxanthine sensors based on xanthine oxidase immobilized on a CuPtCl6 chemically modified electrode and liquid chromatography electrochemical detection | |
Yao et al. | Amperometric assays of total and free cholesterols in serum by the combined use of immobilized cholesterol esterase and cholesterol oxidase reactors and peroxidase electrode in a flow injection system | |
CA1223638A (fr) | Systemes d'analyse utilisant plus d'un enzyme | |
EP0856064A1 (fr) | Capteur electrochimique contenant une peroxydase derivee du soja | |
Ivnitskii et al. | A potentiometric biosensor for pesticides based on the thiocholine hexacyanoferrate (III) reaction | |
Curulli et al. | Bienzyme amperometric probes for choline and choline esters assembled with nonconducting electrosynthesized polymers | |
Gruss et al. | Electrochemical determination of cholinesterase activity and indication of its inhibitors using a thick-film metallized platinum electrode | |
Wingard Jr et al. | Effect of enzyme-matrix composition on potentiometric response to glucose using glucose oxidase immobilized on platinum | |
Iwuoha et al. | Reactivities of organic-phase biosensors. 1. Enhancement of the sensitivity and stability of amperometric peroxidase biosensors using chemically modified enzymes | |
Yao et al. | On‐line amperometric assay of glucose, L‐glutamate, and acetylcholine using microdialysis probes and immobilized enzyme reactors | |
Wollenberger et al. | Amperometric enzyme sequence electrodes for cholesterol | |
Kelly et al. | Amperometric immunosensor for lactate dehydrogenase LD-1 | |
Groom et al. | Electrical communication between a water-soluble 1, 1′-dimethylferrocene-2-hydroxypropyl-β-cyclodextrin complex and glucose oxidase: biosensor applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1986901446 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1986901446 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1986901446 Country of ref document: EP |